Is HRMY or HYFT more undervalued in 2026?

CirclFi compares Harmony Biosciences Holdings, I (HRMY) and MindWalk Holdings Corp. (HYFT) using 13 institutional-grade valuation models. HRMY has a Quality of Company score of 10.0/10 while HYFT scores 1.7/10.

Which is a better buy — HRMY or HYFT?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do HRMY and HYFT valuations compare?

HRMY at $31.59 and HYFT at $1.76 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

HRMY vs HYFT Valuation Comparison 2026 — Intrinsic Value Analysis

HRMY

Pharmaceutical Preparations

Harmony Biosciences Holdings, I

Quality

10.0

out of 10

Value Trap

SAFE

Price

$31.59

Last close

Models

12/13

Active

HYFT

Pharmaceutical Preparations

MindWalk Holdings Corp.

Quality

1.7

out of 10

Value Trap

—

Price

$1.76

Last close

Models

8/13

Active

Model-by-Model Comparison

Model	Type	HRMY Fair Value	HRMY Upside	HYFT Fair Value	HYFT Upside
Bayesian DCF	Intrinsic	$97.88	+209.8%	$0.42	-75.9%
Earnings Power Value	Intrinsic	$23.18	-26.6%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$31.92	+1.0%	$1.40	-20.7%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for HRMY vs HYFT — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

HRMY vs HYFT — Which Stock Is More Undervalued?

HRMY scores higher with a 10.0/10 quality rating vs HYFT's 1.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Harmony Biosciences Holdings, I (HRMY) and MindWalk Holdings Corp. (HYFT) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

HRMY currently trades at $31.59 with a QOC of 10.0/10, while HYFT trades at $1.76 with a QOC of 1.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).